EUVIMEDObjevte EUVIMED
Klinische Studie

Chronic Red Cell Exchange for the Management of Alpha Thalassemia Major Complicated by Iron Overload

Daniel Y Chang, Sanjana B Shah, Arielle Langer iD, Dale Davis, Sean Stowell, Suhayla Sarhan, Kristine Geary, Nelya Christiansen, Kendra Munkacsy, Roger Belizaire, Hiro Nakahara iD, Ryan Jajosky iD and 5 more

Journal of Clinical Apheresis · 2026-06 · 41 (3)

DOI: 10.1002/jca.70147 ↗

At a glance

Klinische Studie in Journal of Clinical Apheresis, published online on 2026-06-22. Written by Daniel Y Chang and 16 co-authors. Institution: Department of Pathology, Mass General Brigham, Boston, Massachusetts, USA. Major MEDLINE topics: alpha-Thalassemia, Erythrocyte Transfusion, Iron Overload. 15 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Alpha thalassemia major is a severe hemoglobinopathy characterized by absent or markedly reduced alpha‐globin production, necessitating lifelong blood transfusions. Chronic simple transfusions can lead to significant iron overload, often requiring iron chelation therapy. However, some patients are unable to tolerate chelation or chelation is insufficient, highlighting the need for alternative strategies for managing iron overload. This study is one of the first to evaluate the feasibility, safety, and efficacy of red blood cell exchange (RBCX) as a therapeutic option for managing iron overload while improving hemoglobin function in an alpha thalassemia major patient with iron overload despite chelation therapy. RBCX therapy was performed approximately every 3 weeks over 1 year, with frequent adjustment of exchange parameters to meet pre‐transfusion target levels of functional hemoglobin. Serum ferritin levels, hemoglobin electrophoresis, and functional hemoglobin levels were tracked with each exchange transfusion. For each RBCX treatment, variant hemoglobins decreased by 3.8‐fold (from 19.9% to 8.9%) and functional hemoglobin levels increased approximately 3.0 g/dL. RBCX was well tolerated and associated with a marked reduction in systemic iron burden, with serum ferritin declining 7.4‐fold (86.4%) over 1 year of therapy, followed by a rise after cessation of RBCX. Cardiac iron remained within normal limits throughout the study period. In contrast, liver iron demonstrated a transient increase shortly after initiation of RBCX, but ultimately declined to levels below baseline after 1 year, even during a period in the absence of iron chelation. These findings suggest that RBCX exerts a meaningful effect on iron homeostasis and raises the possibility of a synergistic benefit when combined with iron chelation. This case highlights that RBCX is a viable therapeutic strategy to treat iron overload in patients with alpha thalassemia major.

Subjects

MeSH terms (MEDLINE)

alpha-ThalassemiaErythrocyte TransfusionIron OverloadAdultFemaleHumansMaleChelation TherapyFerritinsHemoglobinsIronIron Chelating AgentsLiverSingle-Case Studies as Topic

Substances

FerritinsHemoglobinsIronIron Chelating Agents

Authors and institutions

  • Department of Pathology, Mass General Brigham, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Hematology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA.

ORCID profiles: Arielle Langer, Hiro Nakahara, Ryan Jajosky, David Justus, Li Chai, Mischa Covington, Jun Liu

Cite

APA

Chang, D. Y., Shah, S. B., Langer, A., Davis, D., Stowell, S., Sarhan, S., Geary, K., Christiansen, N., Munkacsy, K., Belizaire, R., Nakahara, H., Jajosky, R., Justus, D., Chai, L., Manis, J., Covington, M., & Liu, J. (2026). Chronic Red Cell Exchange for the Management of Alpha Thalassemia Major Complicated by Iron Overload. Journal of Clinical Apheresis, 41(3). https://doi.org/10.1002/jca.70147

Vancouver

Chang DY, Shah SB, Langer A, Davis D, Stowell S, Sarhan S, et al. Chronic Red Cell Exchange for the Management of Alpha Thalassemia Major Complicated by Iron Overload. Journal of Clinical Apheresis. 2026;41(3). doi:10.1002/jca.70147

BibTeX
@article{Chang2026,
  author = {Chang, Daniel Y and Shah, Sanjana B and Langer, Arielle and Davis, Dale and Stowell, Sean and Sarhan, Suhayla and Geary, Kristine and Christiansen, Nelya and Munkacsy, Kendra and Belizaire, Roger and Nakahara, Hiro and Jajosky, Ryan and Justus, David and Chai, Li and Manis, John and Covington, Mischa and Liu, Jun},
  title = {Chronic Red Cell Exchange for the Management of Alpha Thalassemia Major Complicated by Iron Overload},
  journal = {Journal of Clinical Apheresis},
  year = {2026},
  volume = {41},
  number = {3},
  doi = {10.1002/jca.70147}
}
Start for free →